CHRS
Coherus Oncology, Inc. · Healthcare
Chief Scientific Officer Vladimir Vexler sold $1.2M of Coherus Oncology, Inc.
Sold$1,221,150
$18.19Price
67,138Shares
−65%Stake
What CHRS did after the filing
Prices for CHRS after this filing aren't in yet.
Traded Wed, Dec 9. Filed Fri, Dec 11, 11:39 AM ET, during the session. Not investment advice.